Shikiar Asset Management Inc Madrigal Pharmaceuticals, Inc. Transaction History

Shikiar Asset Management Inc

$343 Million
Q1 2024

A detailed history of Shikiar Asset Management Inc transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Shikiar Asset Management Inc holds 5,400 shares of MDGL stock, worth $1.58 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

5,400

Previous 5,000 8.0%

Holding current value

$1.58 Million

Previous $1.16 Million 24.63%

% of portfolio

0.42%

Previous 0.36%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	BUY	$171.37 - $283.23 $68,548 - $113,292	400 Added 8.0%	5,400 $1.44 Million
Q3 2023 Oct 31, 2023	SELL	$146.04 - $225.78 $219,060 - $338,670	-1,500 Reduced 23.08%	5,000 $730,000
Q2 2022 Jul 15, 2022	SELL	$58.04 - $100.2 $203,140 - $350,700	-3,500 Reduced 35.0%	6,500 $465,000
Q1 2022 Apr 13, 2022	SELL	$55.89 - $101.89 $55,890 - $101,890	-1,000 Reduced 9.09%	10,000 $981,000
Q4 2021 Jan 21, 2022	SELL	$72.34 - $95.09 $108,510 - $142,635	-1,500 Reduced 12.0%	11,000 $932,000

Q3 2021 Oct 29, 2021	SELL	$78.35 - $105.02 $117,524 - $157,530	-1,500 Reduced 10.71%	12,500 $997,000
Q2 2021 Jul 16, 2021	BUY	$97.2 - $137.59 $291,600 - $412,770	3,000 Added 27.27%	14,000 $1.36 Million
Q1 2021 May 05, 2021	SELL	$108.54 - $125.2 $108,540 - $125,200	-1,000 Reduced 8.33%	11,000 $1.29 Million
Q1 2020 May 01, 2020	SELL	$66.76 - $93.49 $360,504 - $504,846	-5,400 Reduced 31.03%	12,000 $801,000
Q4 2019 Jan 28, 2020	BUY	$84.28 - $118.5 $89,252 - $125,491	1,059 Added 6.48%	17,400 $1.59 Million
Q3 2019 Oct 29, 2019	BUY	$84.4 - $106.53 $84,400 - $106,530	1,000 Added 6.52%	16,341 $1.41 Million
Q1 2019 Apr 30, 2019	BUY	$103.48 - $143.84 $103,480 - $143,840	1,000 Added 6.97%	15,341 $1.92 Million
Q4 2018 Feb 01, 2019	SELL	$94.77 - $215.54 $94,770 - $215,540	-1,000 Reduced 6.52%	14,341 $1.62 Million
Q3 2018 Nov 05, 2018	SELL	$207.3 - $300.31 $456,060 - $660,682	-2,200 Reduced 12.54%	15,341 $3.29 Million
Q2 2018 Jul 27, 2018	SELL	$101.55 - $313.9 $456,975 - $1.41 Million	-4,500 Reduced 20.42%	17,541 $4.91 Million
Q1 2018 Apr 16, 2018	SELL	$93.35 - $149.04 $102,685 - $163,944	-1,100 Reduced 4.75%	22,041 $2.57 Million
Q3 2017 Oct 20, 2017	BUY	$15.48 - $46.19 $358,222 - $1.07 Million	23,141	23,141 $1.04 Million

Others Institutions Holding MDGL

# of Institutions

314

Shares Held

20M

Call Options Held

824K

Put Options Held

1.04M

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.01B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shikiar Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Shikiar Asset Management Inc with notifications on news.

Account

Shikiar Asset Management Inc Madrigal Pharmaceuticals, Inc. Transaction History